Login / Signup

A novel role for nucleolin in splice site selection.

Kinneret SheferAyub BoulosValer GoteaMaram ArafatYair Ben ChaimAya MuharramSara IsaacAmir EdenJoseph SperlingLaura ElnitskiRuth Sperling
Published in: RNA biology (2021)
Latent 5' splice sites, not normally used, are highly abundant in human introns, but are activated under stress and in cancer, generating thousands of nonsense mRNAs. A previously proposed mechanism to suppress latent splicing was shown to be independent of NMD, with a pivotal role for initiator-tRNA independent of protein translation. To further elucidate this mechanism, we searched for nuclear proteins directly bound to initiator-tRNA. Starting with UV-crosslinking, we identified nucleolin (NCL) interacting directly and specifically with initiator-tRNA in the nucleus, but not in the cytoplasm. Next, we show the association of ini-tRNA and NCL with pre-mRNA. We further show that recovery of suppression of latent splicing by initiator-tRNA complementation is NCL dependent. Finally, upon nucleolin knockdown we show activation of latent splicing in hundreds of coding transcripts having important cellular functions. We thus propose nucleolin, a component of the endogenous spliceosome, through its direct binding to initiator-tRNA and its effect on latent splicing, as the first protein of a nuclear quality control mechanism regulating splice site selection to protect cells from latent splicing that can generate defective mRNAs.
Keyphrases
  • quality control
  • endothelial cells
  • squamous cell carcinoma
  • protein protein
  • amino acid
  • squamous cell
  • lymph node metastasis
  • protein kinase